Impairment of hepatic Bromsulphalein clearance by two 17-substituted testosterones

Robert P. Heaney, G. Donald Whedon

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Two 17-substituted testosterones in common clinical use (methyltestosterone and norethandrolone), administered orally in doses ranging from 20 to 100 mg. per day, have been observed to produce marked elevations in 45-minute BSP retention and corresponding reductions in BSP clearance in all subjects treated with these agents. These effects were not observed with testosterone propionate at either equimolecular or equivalent anabolic doses. The BSP changes were unaccompanied by clinical jaundice, or by alterations in any of several common laboratory indices of liver function. Maximum depression of serum BSP clearance occurred within 7 to 10 days after starting therapy, and conversely normal clearance was usually restored within a similar period after stopping treatment. Indirect evidence indicates that the defect involves the hepatic excretory mechanism rather than liver dye uptake. The significance of this change is uncertain, but it is presumed not to represent liver damage.

Original languageEnglish
Pages (from-to)169-175
Number of pages7
JournalThe Journal of Laboratory and Clinical Medicine
Volume52
Issue number2
StatePublished - Aug 1958
Externally publishedYes

Fingerprint

Sulfobromophthalein
Liver
Testosterone
Norethandrolone
Methyltestosterone
Testosterone Propionate
Coloring Agents
Jaundice
Defects
Serum

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

Impairment of hepatic Bromsulphalein clearance by two 17-substituted testosterones. / Heaney, Robert P.; Whedon, G. Donald.

In: The Journal of Laboratory and Clinical Medicine, Vol. 52, No. 2, 08.1958, p. 169-175.

Research output: Contribution to journalArticle

@article{68f325e3759d4ca987581701da494a9d,
title = "Impairment of hepatic Bromsulphalein clearance by two 17-substituted testosterones",
abstract = "Two 17-substituted testosterones in common clinical use (methyltestosterone and norethandrolone), administered orally in doses ranging from 20 to 100 mg. per day, have been observed to produce marked elevations in 45-minute BSP retention and corresponding reductions in BSP clearance in all subjects treated with these agents. These effects were not observed with testosterone propionate at either equimolecular or equivalent anabolic doses. The BSP changes were unaccompanied by clinical jaundice, or by alterations in any of several common laboratory indices of liver function. Maximum depression of serum BSP clearance occurred within 7 to 10 days after starting therapy, and conversely normal clearance was usually restored within a similar period after stopping treatment. Indirect evidence indicates that the defect involves the hepatic excretory mechanism rather than liver dye uptake. The significance of this change is uncertain, but it is presumed not to represent liver damage.",
author = "Heaney, {Robert P.} and Whedon, {G. Donald}",
year = "1958",
month = "8",
language = "English",
volume = "52",
pages = "169--175",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Impairment of hepatic Bromsulphalein clearance by two 17-substituted testosterones

AU - Heaney, Robert P.

AU - Whedon, G. Donald

PY - 1958/8

Y1 - 1958/8

N2 - Two 17-substituted testosterones in common clinical use (methyltestosterone and norethandrolone), administered orally in doses ranging from 20 to 100 mg. per day, have been observed to produce marked elevations in 45-minute BSP retention and corresponding reductions in BSP clearance in all subjects treated with these agents. These effects were not observed with testosterone propionate at either equimolecular or equivalent anabolic doses. The BSP changes were unaccompanied by clinical jaundice, or by alterations in any of several common laboratory indices of liver function. Maximum depression of serum BSP clearance occurred within 7 to 10 days after starting therapy, and conversely normal clearance was usually restored within a similar period after stopping treatment. Indirect evidence indicates that the defect involves the hepatic excretory mechanism rather than liver dye uptake. The significance of this change is uncertain, but it is presumed not to represent liver damage.

AB - Two 17-substituted testosterones in common clinical use (methyltestosterone and norethandrolone), administered orally in doses ranging from 20 to 100 mg. per day, have been observed to produce marked elevations in 45-minute BSP retention and corresponding reductions in BSP clearance in all subjects treated with these agents. These effects were not observed with testosterone propionate at either equimolecular or equivalent anabolic doses. The BSP changes were unaccompanied by clinical jaundice, or by alterations in any of several common laboratory indices of liver function. Maximum depression of serum BSP clearance occurred within 7 to 10 days after starting therapy, and conversely normal clearance was usually restored within a similar period after stopping treatment. Indirect evidence indicates that the defect involves the hepatic excretory mechanism rather than liver dye uptake. The significance of this change is uncertain, but it is presumed not to represent liver damage.

UR - http://www.scopus.com/inward/record.url?scp=49749175358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49749175358&partnerID=8YFLogxK

M3 - Article

VL - 52

SP - 169

EP - 175

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 2

ER -